Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market: By Application: Depression, Anxiety and Panic Disorder, Other Mental Conditions; Regional Analysis; Historical Market and Forecast (2016-2026); SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Outlook

The global selective serotonin reuptake inhibitors (SSRIs) market is expected to grow in the forecast period of 2021-2026 at a CAGR of nearly 4.2%. The market is being driven by the rising geriatric population.

 

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

SSRIs cure depression through increasing serotonin concentrations in the brain. Serotonin is among the chemical (neurotransmitter) messengers carrying messages between brain nerve cells (neurons). SSRIs are used to block serotonin reabsorption (reuptake) into neurons. This increases the transfer of signals between neurons by more serotonin. SSRIs can also be used to treat non-depression conditions, like anxiety disorders.

 

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The market can be broadly categorised based on its applications into:

  • Depression
  • Anxiety and Panic Disorder
  • Other Mental Conditions

The EMR report looks into the regional markets of selective serotonin reuptake inhibitors (SSRIs) like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increasing prevalence of mental illnesses is one of the key factors driving the expansion of the global selective serotonin reuptake inhibitors (SSRIs) industry. Mental disease has eventually become one of the most diagnosed disorders worldwide. The increasing prevalence of mental illness leads to an increased number of patients who require effective neurological therapy. In this context, mentally ill patients are more likely to opt for SSRIs for antidepressant medicines because of the improved therapeutic efficacy of SSRIs. The increased prevalence of mental illnesses is therefore expected in the forecast period to fuel the growth of the SSRI market. The application sector was being dominated by the depression segment in 2020.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global selective serotonin reuptake inhibitors (SSRIs) industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Allergan Plc (NYSE: AGN)
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • H. Lundbeck A/S
  • Pfizer Inc.
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6     Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Analysis
    6.1    Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market (2016-2020) & Forecast (2021-2026)
    6.2    Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Breakup by Application
            6.2.1    Depression 
            6.2.2    Anxiety and Panic Disorder 
            6.2.3    Other Mental Conditions 
        6.3    Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Breakup by Application: Historical Market (2016-2020) & Forecast (2021-2026)
            6.3.1    Depression 
            6.3.2    Anxiety and Panic Disorder 
            6.3.3    Other Mental Conditions 
        6.4    Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Breakup by Region
            6.4.1    North America
                6.4.1.1    United States of America
                6.4.1.2    Canada
            6.4.2    Europe
                6.4.2.1    Germany
                6.4.2.2    United Kingdom
                6.4.2.3    France
                6.4.2.4    Italy
                6.4.2.5    Others
            6.4.3    Asia Pacific
                6.4.3.1    China
                6.4.3.2    Japan
                6.4.3.3    India
                6.4.3.4    ASEAN
                6.4.3.5    Others
            6.4.4    Latin America
                6.4.4.1    Brazil
                6.4.4.2    Argentina
                6.4.4.3    Mexico
                6.4.4.4    Others
            6.4.5    Middle East & Africa
                6.4.5.1    Saudi Arabia
                6.4.5.2    United Arab Emirates
                6.4.5.3    Nigeria
                6.4.5.4    South Africa
                6.4.5.5    Others
    6.5     Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Argentina
            6.5.4.3    Mexico
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis
    9.1    Allergan Plc [AGN (NYSE)]
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Eli Lilly and Co.
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    GlaxoSmithKline Plc
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    H. Lundbeck A/S
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Pfizer Inc.
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Others
10    Industry Events and Developments

Additional Customisations Available:

1    Manufacturing Process
    1.1    Detailed Process Flow
    1.2    Operations Involved
    1.3    Mass Balance
2    Cost Analysis and Project Economics
    2.1    Land, Location and Site Development
    2.2    Construction
    2.3    Plant Machinery
    2.4    Cost of Raw Material
    2.5    Packaging
    2.6    Transportation
    2.7    Utilities
    2.8    Manpower
    2.9    Other Capital Investment

Key Questions Answered in the Report

The global selective serotonin reuptake inhibitors (SSRIs) market is projected to grow at a CAGR of 4.2% between 2021 and 2026.

The major drivers of the industry, such as the rising disposable incomes, increasing health awareness, increasing geriatric population, and growing technological advancements, are expected to aid the market growth.

The key market trend guiding the growth of the selective serotonin reuptake inhibitors (SSRIs) industry includes the increasing prevalence and awareness of mental illnesses.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Depression, anxiety and panic disorder, and other mental conditions are the major application sectors of selective serotonin reuptake inhibitors (SSRIs) in the industry.

The major players in the industry are Allergan Plc, Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck A/S, and Pfizer Inc., among others.

Analyst Review

The global selective serotonin reuptake inhibitors (SSRIs) market is being driven by the increasing prevalence of mental illnesses. Aided by growing health awareness, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 4.2%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its applications, the global selective serotonin reuptake inhibitors (SSRIs) industry can be segmented into depression, anxiety and panic disorder, and other mental conditions. The major regional markets for selective serotonin reuptake inhibitors (SSRIs)s are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Allergan Plc, Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck A/S, Pfizer Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

United States Compounding Pharmacies Market Report and Forecast 2021-2026


Global Anaesthesia Drugs Market Report and Forecast 2021-2026


United States HIV Drugs Market Report and Forecast 2021-2026


Global Parkinson’s Disease Drugs Market Report and Forecast 2021-2026


Global Nootropics Market Report and Forecast 2021-2026


NEWSLETTER